ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,165Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 944

$636K Total Retail Price of All Prescriptions

Rank: 96 out of 944

629 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 629 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 629 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 13,540 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 1,001 978 1 1
LEVOTHYROXINE SODIUM 718 651 2 2
AMLODIPINE BESYLATE 659 649 3 5
LISINOPRIL 507 484 4 3
WARFARIN SODIUM 452 437 5 7
TRIAMTERENE-HCTZ 438 419 6 33
METOPROLOL TARTRATE 402 399 7 8
FUROSEMIDE 303 301 8 6
METFORMIN HCL ER 300 283 9 49
METOPROLOL SUCCINATE 299 272 10 14
ATENOLOL 285 273 11 11
POTASSIUM CHLORIDE 259 255 12 15
OMEPRAZOLE 239 237 13 4
ATORVASTATIN CALCIUM 214 206 14 13
ALENDRONATE SODIUM 214 202 14 20
DONEPEZIL HCL 214 214 14 24
GABAPENTIN 199 186 17 18
HYDROCHLOROTHIAZIDE 192 189 18 9
HYDROCODONE-ACETAMINOPHEN 189 186 S3 19 10
ALLOPURINOL 179 162 20 22
GLIPIZIDE ER 177 150 21 89
LOSARTAN POTASSIUM 168 155 22 16
DIGOXIN 162 160 23 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 142 142 24 29
ENALAPRIL MALEATE 140 135 25 43
PRAVASTATIN SODIUM 133 122 26 17
PANTOPRAZOLE SODIUM 125 113 27 34
LOVASTATIN 114 114 28 26
CITALOPRAM HBR 109 97 29 19
NAMENDA 104 104 30 37
GEMFIBROZIL 103 103 31 72
TAMSULOSIN HCL 102 99 32 27
SPIRONOLACTONE 96 96 33 44
TRAMADOL HCL 89 89 34 21
LANTUS 89 89 34 46
SERTRALINE HCL 87 81 36 23
LOSARTAN-HYDROCHLOROTHIAZIDE 82 82 37 54
POLYETHYLENE GLYCOL 3350 82 82 37 41
ZOLPIDEM TARTRATE 78 73 39 25
TRIAMTERENE-HYDROCHLOROTHIAZID 76 74 40 137
PREDNISONE 76 74 40 32
DILTIAZEM ER 74 74 42 88
QUINAPRIL HCL 72 72 43 131
RAMIPRIL 69 69 44 144
AZITHROMYCIN 69 63 44 70
CLOPIDOGREL 68 68 46 36
FENOFIBRATE 66 58 47 58
NEXIUM 65 65 48 53
ADVAIR DISKUS 64 63 49 31
SYNTHROID 63 56 50 82
PROAIR HFA 61 61 51 56
ISOSORBIDE MONONITRATE ER 60 60 52 52
METFORMIN HCL 58 53 53 12
FINASTERIDE 58 58 53 83
CRESTOR 57 57 55 28
MIRTAZAPINE 52 50 56 35
JANUVIA 51 32 57 81
HYDRALAZINE HCL 50 50 58 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.